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Osteosarcoma is the most common bone cancer with limited therapeutic options.
It can be treated by selenium-doped hydroxyapatite owing to its known antitumor
potential. However, a high concentration of Se is toxic toward normal and stem cells
whereas its low concentration cannot effectively remove cancer cells. Therefore, the
current study was aimed to improve the anticancer activity of Se-HAp nanoparticles
through catechins (CC) modification owing to their high cancer therapeutic value. The
sequentially developed catechins modified Se-HAp nanocomposites (CC/Se-HAp) were
characterized for various physico-chemical properties and antitumor activity. Structural
analysis showed the synthesis of small rod-like single phase HAp nanoparticles (60 ±
15 nm), which effectively interacted with Se and catechins and formed agglomerated
structures. TEM analysis showed the internalization and degradation of CC/Se-HAp
nanomaterials within MNNG/HOS cells through a non-specific endocytosis process. Cell
toxicity analysis showed that catechins modification improved the antitumor activity of
Se-HAp nanocomposites by inducing apoptosis of human osteosarcoma MNNG/HOS
cell lines, through generation of reactive oxygen species (ROS) which in turn activated
the caspase-3 pathway, without significantly affecting the growth of human normal bone
marrow stem cells (hBMSCs). qPCR and western blot analyses revealed that casp3,
p53, and bax genes were significantly upregulated while cox-2 and PTK-2 were slightly
downregulated as compared to control in CC/Se-HAp-treated MNNG/HOS cell lines.
The current study of combining natural biomaterial (i.e., catechins) with Se and HAp, can
prove to be an effective therapeutic approach for bone cancer therapy.
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INTRODUCTION
Cancer is the major health concerns and the second leading
cause of death all over the world (1). Osteosarcoma, a commonly
known bone cancer, cause malignant primary bone tumor with
a high mortality rate, both in children and adolescents (2).
It can easily metastasize to lungs after its germination in the
distal femur and proximal tibia (3–8). In addition, the difficulty
in cleaning up after the treatment increases the probability
of recurrent osteosarcoma. Furthermore, the defects caused
by surgery need to be filled for bone repair to relieve the
physical limitations to patients. Therefore, extensive efforts have
been devoted to the development of advanced targeted drug
delivery systems and heat mediators to regulate oncogenes and
tumorigenesis in treating osteosarcoma (9, 10).
The bone strength mainly relies on selenium (Se), calcium
(Ca), and vitamins (K and D) contents. It is further enhanced by
the addition of several other trace elements, such as manganese
(Mn), zinc (Zn), fluorine (F), copper (Cu), magnesium (Mg),
strontium (Sr), boron (B), and iron (Fe), etc. (11–15). Se
deficiency is associated with the risk of developing multiple
cancers; such as in bone, breast, ovary, prostate, gastrointestinal
tract, and lungs (16, 17). To minimize the risk associated
with the Se deficiency, its doping with hydroxyapatite (HAp)
can be an effective approach which may potentially reduce
the growth of osteosarcoma cells. Currently, HAp has received
immense consideration in reconstructive surgeries, orthodontic,
orthopedic substances, and three-dimensional printing of
scaffolds owing to its high bioactive and osteoconductive
properties (18–20). Its large surface area allows it to strongly
interact with the neighboring bone and connective tissues in
vivo. Se prevents the cancer development through generation
of reactive oxygen species (ROS) (16); however, it possesses
low anticancer activity when used at low concentrations, while
its higher concentration can potentially inhibit the growth of
normal cells leading toward osteosarcoma (21). This necessitates
the improvement of its anticancer activity while still retaining
its low or no toxicity toward the normal cells. To this end,
its modification with another anticancer reagent to improve
its antitumor activity can have the additive effect toward the
osteosarcoma cells.
Green tea contains several important chemical reagents,
among which 30% are catechins including epigallocatechin
gallate (EGCG), epigallocatechin (EGC), epicatechin gallate
(ECG), and epicatechin (EC). These play a preventive role
against the development of different types of cancers (22–25). A
recent study by Stadlbauer et al. suggested that epicatechin-3-O-
gallate and 5,7-difluoro-epicatechin-3-O-gallate can potentially
prevent the tumorigenesis during the initiation, promotion, and
progression of cancer by diminishing the inflammation level
through reduction of inflammatory lymphocytes (26). Similarly,
EGCG affects several signal transduction pathways related to
cancer development and exhibits strong anticancer activity
by targeting several cell signaling pathways causing tumor
growth suppression, induction of apoptosis through generation
of reactive oxygen species, and inhibition of metastasis and
angiogenesis (25, 27–30). In addition, it also exerts anticancer
activity by acting as a chemo/radio-sensitizer when combined
with conventional therapies (31). In vitro and in vivo studies have
demonstrated that catechins control the cancer development by
different mechanisms, such as through induction of apoptosis
to control the cell growth arrest, through altered expression
of cell-cycle regulatory proteins, by activating killer caspases,
and through suppression of nuclear factor kappa-B activation
(23). Catechins also act as carcinoma blockers by modulating
the signal transduction pathways, involved in cell proliferation,
transformation, inflammation, and metastasis (29, 32–37).
Owing to the known antitumor properties of catechins, the
current study was aimed to develop catechins-modified Se-doped
HAp nanocomposites (CC/Se-HAp) for potential application
in osteosarcoma therapy. The developed nanocomposites
were characterized by various physico-chemical and biological
properties. The sequential self-assembly of green tea-derived
catechins with Se-doped HAp resulted in formation of stable
nanocomplexes which showed improved anticancer activity
in vitro as compared to Se-doped HAp nanocomposite. These
nanocomposites enhanced the ROS-mediated apoptosis through
activation of caspase-3 pathway. These findings demonstrate
the antitumor potential of the developed catechin-modified
Se-doped HAp nanocomposites with the improved outcome to
prevent the adverse and toxic effects of high concentration of Se
toward the normal cells for cancer therapy.
MATERIALS AND METHODS
Materials
The chemical reagents, including calcium nitrate tetrahydrate
(Ca(NO3)2.4H2O) and sodium selenite (Na2SiO3), were
purchased from National Medicine Chemical Reagent Company
(China). Ammonium hydrogen phosphate ((NH4)2HPO4)
was purchased from Regal Biotech Technology, Inc.
(Shanghai, China), whereas sodium polyacrylate [[[Inline
Image]]CH2[[InlineImage]]CH(CO2Na)[[Inline Image]]]n (PPAS)
(MW: 5100) from Sigma-Aldrich (St. Louis, MO, USA).
Commercial Brazilian green tea was purchased from a tea center
(Peshawar, Pakistan). In all experiments, ultrapure deionized
(DI) distilled water was used. Dulbecco’s Modified Eagle Medium
(DMEM), fetal bovine serum (FBS), eagle’s modified minimum
essential medium (MEM), streptomycin, and penicillin were
obtained from Hyclone (USA). The cell counting kit-8 (CCK-8)
was purchased from Sigma Aldrich (St. Louis, USA).
Cell Culturing
Human osteosarcoma cell lines (MNNG/HOS) were kindly
provided by Tongji Medical College of Huazhong University
of Science and Technology, Wuhan, China. The human bone
marrow stem cells (hBMSCs) were purchased from Chinese
Center of Type Culture Collection ofWuhan University, Wuhan,
China. The MNNG/HOS and hBMSCs cells were cultured in
MEM and DMEM media, respectively. Both culture media
were supplemented with 10% fetal bovine serum, 100 mg/mL
streptomycin, and 100 unit/mL penicillin, and kept in an
incubator at 37◦C (5% CO2, 95% relative humidity). The culture
media for both cell lines were refreshed after 24 h.
Frontiers in Oncology | www.frontiersin.org 2 June 2019 | Volume 9 | Article 499
Khan et al. Therapeutic Nanomaterials for Bone Cancer
Synthesis of HAp Nanoparticles
The pristine HAp nanoparticles were synthesized via aqueous
precipitation method followed by sonication technique using
calcium nitrate tetrahydrate (Ca(NO3)2·4H2O), ammonium
hydrogen phosphate ((NH4)2HPO4), and ammonium hydroxide
(HN4OH) solution as reported previously (15). A schematic
representation of preparation of HAp nanoparticles is shown
in Supplementary Figure S1. Briefly, 1.0M calcium nitrate
tetrahydrate solution was prepared in DI water with the desired
concentrations of sodium selenite. The pH was adjusted to 10.5
with 25% (v/v) ammonium hydroxide solution. Thereafter, 0.6M
ammonium hydrogen phosphate solution (pH ≥ 9) was added
dropwise (2.0–2.5 mL/min) into the cationic mixture to form a
white precipitated mixture. The precipitated mixture was stirred
for 4 h at 70◦C, using sodium polyacrylate (PPAS, MW 5100) as
a dispersant, followed by sonication for 20min and allowed to
settle down at room temperature for 24 h, until the formation of
gel. The gel was collected via centrifugation, washed three-times
with DI water, and dried at 60◦C in a hot air oven.
Synthesis of Se-Doped HAp and
CC/Se-HAp Nanocomposites
The stoichiometric Se-doped HAp and CC/Se-HAp
nanocomposites were prepared by a modified aqueous co-
precipitation method (16), using ammonium hydrogen
phosphate, calcium nitrate tetrahydrate, and sodium selenite
were used as sources of phosphorous (P), calcium (Ca),
and selenium (Se), respectively (Table S1). Briefly, Se-
HAp nanomaterial was prepared through dropwise and
simultaneous addition of aqueous solutions of 5.45mM
(NH4)2HPO4 and 0.55mM Na2SeO3 into the aqueous solution
of Ca(NO3)2·4H2O, under vigorous stirring at 70◦C. The pH
was adjusted to 10.5 with 25% (v/v) ammonium hydroxide
solution (Supplementary Figure S1, middle). The precipitate
was stirred continuously for 24 h at 70◦C, using PAAS as a
dispersant, until the formation of a semitransparent and well-
dispersed gel. This gel was then collected via centrifugation,
washed three-times with DI water, and dried at 60◦C in a hot air
oven. For preparation of CC/Se-HAp nanocomposites, different
catechins solutions (CC-1, CC-2, and CC-3) were prepared from
green tea (Supplementary Material), and subsequently used
to prepare CC/Se-HAp-1, CC/Se-HAp-2, and CC/Se-HAp-3
nanocomposites, respectively (Supplementary Figure S1).
Characterization
The synthesized pristine HAp nanoparticles, and Se-HAp and
CC/Se-HAp nanocomposites were characterized for various
structural and chemical properties. The phase composition of
synthesized HAp, Se-HAp, and CC/Se-HAp was investigated by
using XRD (PANalytical B.V., Netherlands). The morphology
of synthesized nanomaterials was examined by transmission
electron microscopy (TEM, Tecnai G2 20, FEI, Holland), while
structural analysis was carried out using Gemini scanning
electron microscope, SEM 300 (Zeiss Germany). FTIR (Vertex
70, Bruker, German) analysis was carried out to investigate the
functional groups present in the pristine nanoparticles, using the
classical KBr pellet system technique in transmission mode (See
Supplementary Material for detailed information).
Cellular Uptake Analysis
The cellular uptake of CC/Se-HAp nanomaterials was
determined through TEM analysis (38). Briefly, the
synthesized nanomaterials were directly added to the culture
dishes, separately containing human osteosarcoma cell line
(MNNG/HOS), at a concentration of 50µg/mL and cultured in
MEM medium for 12 h. The medium was changed after every
2 days. For TEM analysis, the cell sections were immediately
prepared and observed with a specific cell TEM (H-7000FA,
HITACHI, Japan) by following a previously published protocol
(39). Briefly, the overnight cultured seeded cells (1 × 106 cells
per well) were treated with nanomaterials in reduced serum
(MEM) and cell monolayers were rinsed with D-PBS and fixed
in a mixture of 2% paraformaldehyde, 2.5% glutaraldehyde, and
0.15M sodium phosphate at pH 7.4, and incubated overnight
at 37◦C. The monolayers were fixed in a mixture of 1%
osmium tetroxide, 1.25% potassium ferrocyanide, and 0.15M
sodium phosphate buffer and rinsed in DI water. Cells were
embedded in polybed epoxy resin after dehydrating them using
acetone. Finally, the ultrathin sections were stained with 4%
aqueous uranyl acetate and Reynolds’ lead citrate and observed
under TEM.
In vitro Cytotoxicity Assay
The cytotoxic effects of Se-HAp, CC/Se-HAp, and NaSeO3
(control) against human bone marrow stem cells (hBMSCs) and
human osteosarcoma cell line (MNNG/HOS) were measured
using a CCK-8 assay kit. Briefly, the cells were seeded at a
density of 1 × 104 cells per well in a 96-well plate followed
by adding 100µg/mL of each nanomaterial to respective well.
The plates were incubated for 6, 12, 18, 24, 36, 42, and 48 h.
After incubation, the portion of viable cells was determined
using CCK-8 assay according to the manufacturer’s protocol
(Supplementary Material). Optical density (OD) values were
measured for all samples at 450 nm using a microplate reader
(Eon, BioTek, USA). The viability of cells was expressed as a
percentage of untreated control cells.
Caspase-3 Activity Assay
Caspase-3 activity was assessed calorimetrically using the
CaspACE Assay System (Promega, Madison, WI, USA),
following the manufacturer’s instructions. The MNNG/HOS
cells at a density of 1× 106 cells per well were treated with caspase
inhibitor Ac-DEVD-CHO (or antioxidant N-acetyl-cysteine).
Cells were then treated with CC/Se-HAp nanomaterials and
incubated for 18 h prior to lysis. Cell lysates were incubated with
the caspase-3 substrate for 4 h. Free Ac-DEVD-p-nitroaniline
was monitored by a spectrophotometer at 405 nm.
Determination of Intracellular ROS Level
ROS generation was measured by a previously reported method
using a non-fluorescent probe, 2,7-diacetyl dichlorofluorescein
(H2DCFDA) (16, 40). Briefly, the MNNG/HOS cells were
cultured in 6 and 24-well plates at a density of 1 × 106 cells
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per well, for 16 h and incubated with CC/Se-HAp (100µg/mL),
HAp (100µg/mL), and sodium selenite (2µM) for 6, 8, 10, and
24 h. The cells were then incubated with 1µM of DFCH/DA
for 30min at 37◦C and washed three times with phosphate
buffer saline (PBS) and resuspended in PBS. ROS generation was
measured by flow cytometry (Cytomics FC500, BeckmanCoulter,
U.S.A.) at 485 nm excitation and 538 nm emission wavelengths.
To investigate the inhibition effect of ROS generation in the
presence of CC/Se-Hap, N-acetylcysteine (NAC) was added to
each well and cultured for 1 h before incubation with materials
under investigation. The inhibition effect of ROS generation was
also confirmed by adding MnTMPyP (10µM) to each well and
cultured for 1 h before incubation with the nanomaterials.
Western Blot Analysis
Cells were cultured and treated with Na2SeO3, Se-HAp, and
CC/Se-HAp. The cells were then lysed using lysis buffer on ice
for 20min and centrifuged at 12,500 rpm for 10min at 4◦C. The
protein concentration was determined by BCA assay (Thermo-
Fisher Scientific) according to the manufacturer’s instructions.
Loading of 60 µg protein onto SDS-polyacrylamide gel was
followed by electrophoresis and transferred to polyvinylidene
fluoride (PVDF) membrane. The membrane was blocked with
blocking buffer containing TBS [Tween-20 (0.1%), tri-sec-buffer
saline (10%), DI water (89.9%)], and 5% skimmed milk for 2 h
and incubated overnight at 4◦C with monoclonal antibodies
against gapdh, p53, bcl-2, caspase3, caspase9, cox-2, nf-kb,
and bax. The membranes were then soaked with horseradish
peroxidase (HPR)-conjugated secondary antibodies for 1 h at
room temperature. The immunoblots were observed using
chemiluminescence system (Bio-Rad, Hungary Ltd) according to
the manufacturer’s instructions.
Apoptosis Analysis
The qualitative apoptosis of MNNG/HOS cells was determined
by treating comparable number of cells (1 × 106 cells per well)
with both Na2SeO3 and CC/Se-HAp nanomaterials in a 12-well
plate. The cells were washed with PBS and fixed in cold methanol:
acetone solution for 5min. The cells were then treated with
DAPI (4µg/ml 4,6-diamidine-2-phenylindole dihydrochloride)
at room temperature for 10min. The cells were examined by
fluorescence microscopy (Olympus) at 200× magnification. For
quantitative apoptosis study,MNNG/HOS cells were seeded onto
12-well plates (106 cells/well). After incubation, the cells were
treated with Na2SeO3 and CC/Se-HAp, keeping untreated cells
as a control. The cells were trypsinized after incubation for 24 h,
collected, and resuspended in 350 µL binding buffer. Then 4 µL
annexin V-FITC and 8 µL PI were added to the cell suspension
and mixed in dark for 15min prior to flow cytometry analysis.
Quantitative Real-Time Polymerase Chain
Reaction
The apoptosis-related gene expression levels were analyzed using
real-time PCR. The total RNA of cells, both treated with the
nanomaterials under investigation and control, was extracted by
using Trizol reagent according to the manufacturer’s instructions
(Thermo-Fisher, Applied Biosystems). The RNA concentration
was measured using a spectrophotometer. cDNAwas synthesized
using a high capacity RNA to cDNA kit (Thermo-Fisher, Applied
Biosystems). qPCR analysis was performed according to the
standard protocol (Applied Biosystems). The forward and reverse
primers were generated through Primer-BLAST (NCBI) and/or
primer-3.0 (Table S2). Relative gene expression was quantified by
the11CT method using ACTIN as a reference gene.
Statistical Analysis
Results were expressed as means ± SD for each group. The
analyses were performed using the two-tailed student’s t-test.
Statistically significant differences between the control and
CC/Se-HAp nanomaterials were considered at ∗p < 0.05. All
statistical analyses were performed in Prism Software (Graph Pad
Prism 7, La Jolla, CA, USA) and MS Excel 2016 (Microsoft).
RESULTS
Synthesis of CC/Se-HAp Nanomaterials
The catechins-modified selenium-doped hydroxyapatite
nanoparticles (CC/Se-HAp) were synthesized through the
aqueous precipitation method (Figure S1). According to the
previous reports, selenium replaces phosphate during the
synthesis of HAp nanoparticles (16, 19, 21, 41). The synthesized
Se-HAp nanoparticles were modified with catechin contents
through vigorous mixing in a sonicator. It was hypothesized
that catechins modification of Se-HAp nanoparticle will
enhance their anticancer activity owing to the known anticancer
activities of individual catechins and Se-HAp nanoparticles. The
prepared nanomaterials were characterized for various physico-
chemical properties such as size, chemical structure, structural
morphology, and colloidal stability, which are important factors
in the designing of nanoparticles (39).
Structural Analysis of CC/Se-HAp
Nanomaterials
XRD analysis of the as-prepared nanomaterials was carried
out to investigate the basic polymorphic structure of HAp and
any structural variations during the Se-doping and catechins
modification (Figure 1). The XRD spectrum of the extended
linear scanning (10–70◦) of HAp showed characteristic peaks
confirming its successful synthesis, where the peaks were
comparable with the standard HAp (JCPDS card no. 24-0033).
Further, the intense and sharp peaks indicate the crystalline
nature of synthesized HAp nanoparticles. The Se-doping of
HAp slightly altered its crystallinity as indicated by the less
intense crystallinity peaks. The Se-HAp and CC/Se-HAp samples
showed a single phase (solid solution) with a hexagonal structure
[space group, p63/m (176)]. The XRD spectra of CC/Se-
HAp-1, CC/Se-HAp-2, and CC/Se-HAp-3 further indicated
the synthesis of crystalline nanoparticles with crystallinity
scope inferior to pristine HAp and Se-HAp. This crystallinity
scope was further decreased with the increased concentration
of catechins. Additionally, the peak intensities were slightly
shifted toward higher 2θ value and three major differential
peaks (211), (112), and (300) were merged into single peak,
which indirectly indicates the substitution effect with nanosized
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FIGURE 1 | X-ray diffraction spectra of pristine HAp nanoparticles, and
selenium-doped hydroxyapatite (Se-HAp), and modification of Se-HAp
composites with different concentrations of catechins, i.e., 5% (CC/Se-HAp1),
7% (CC/Se-HAp2), and 10% (CC/Se-HAp3). The patterns of XRD depicted
that both HAp and Se-HAp presented the typical HAp peaks, with the no
significant differences. The peak (211) associated CC/Se-HAp showed a
reduction in crystallinity which determines the association of catechin contents.
TABLE 1 | Summary of effect of selenium and catechins contents on the lattice
parameters (a and c), unit cell volume, crystal size, and crystallinity of pristine HAp
and catechins-modified selenium-doped HAp nanocomposites.
Sample Lattice
parameters (Å)
Unit cell
volume (Å)3
Crystallinity
(Xc)
Crystal size
(D002) nm
a c
HAp 9.4482 6.883 532.10 1.612 29.78
Se-HAp 9.3804 6.8547 522.33 1.13 25.45
CC/Se-HAp1 9.3546 6.8499 519.18 0.22 21.58
CC/Se-HAp2 9.3215 6.8676 516.76 0.20 18.91
CC/Se-HAp3 9.2989 6.8442 512.51 0.13 15.89
features. The effect of Se-doping and catechins modification on
lattice parameters (a and c), unit cell volume (Å)3, crystal size
(D), and crystallinity (Xc) are summarized in Table 1.
Chemical Structure Analysis of CC/Se-HAp
Nanomaterials
FTIR spectroscopy was used to investigate the presence of specific
functional groups (Figure 2) (42). The peaks for O-H vibrations
were observed at 633 cm−1 and 3,500–3,000 cm−1. The peak
at 1,640 cm−1 was assigned to the bending mode of H2O
molecule present in the HAp lattice, which are in agreement
with previous reports (41, 43). The peaks observed at 1,486,
1,459, 1,420, 1,424, and 872 cm−1 correspond to the carbonate
(CO2−3 ) groups, which indicated its substitution at PO
−3
4 (B-site)
and OH positions (A-site) in the HAp lattice. The substitution
of CO2−3 in the OH group might result in an increased length
of the unit cell toward the a-axis and a decline toward c-axis,
FIGURE 2 | Fourier transform infrared spectra of pristine HAp, Se-HAp, and
its modification with different concentrations of catechins, i.e., 5%
(CC/Se-HAp1), 7% (CC/Se-HAp2), and 10% (CC/Se-HAp3). The peaks show
that both HAp and Se-HAp presented the typical HAp functional groups, with
a decrease in intensity (1,000 cm−1 ) upon catechins modification.
as reported previously (44). Similarly, the peaks for stretching
vibrations due to OH group were present at 3,570 cm−1 and 630
cm−1 (45, 46) in all spectra of HAp, Se-HAp, and CC/Se-HAp
samples while its intensity was relatively low in the spectrum for
Se-HAp nanocomposite.
Structural Morphology of CC/Se-HAp
Nanomaterials
From Figure 3, TEM analysis showed the formation of small rod-
like structure of various HAp samples under investigation. The
modified aqueous precipitation method effectively maintained
the rod-like morphology of HAp upon doping with Se and
catechins modification, and were well-dispersed in PBS and
formed a stable colloidal suspension even when stored for over
a month.
According to SEM micrographs (Figures 4A–E), the size
of different HAp samples was estimated to be 60 ± 15 nm
as determined via “Fiji v2” software, indicating their nano-
crystalline features. The micrographs of pristine HAp and Se-
HAp showed that the nanoparticles were nearly uniformly
distributed and formed a moderately rough surface with slight
pores, and particles were observed with dominant small rod-like
morphology (Figure 4). In contrast, the Se-HAp samples with
catechins content were highly agglomerated and exhibited dense
rough surface with small rod-like morphology (Figures 4B–E).
These results indicate that incorporation of Se and catechins
content into HAp structure resulted in the synthesis of highly-
agglomerated material and the particles exhibited small rod-like
morphology. The strong agglomeration among the particles was
due to the presence of catechins content which could be defined
by the decreased particle size as confirmed via XRD analysis
(Figure 1). XRF analysis was carried out to confirm the formation
of HAp, Se-HAp, and CC/Se-HAp nanomaterials and to measure
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FIGURE 3 | Transmission electron micrographs of (A) pristine HAp nanoparticles and (B) Se-HAp, (C) CC/Se-HAp1, (D) CC/Se-HAp2, and (E) CC/Se-HAp3
nanocomposites.
the degree of atomic percentage of Se substituted/doped during
the synthesis of nanocomposites. The elemental mapping via
XRF showed that Se distribution in CC/Se-HAp was reduced
in comparison with HAp and Se-HAp where it was evenly
distributed in the entire nanocomposite and was comparable to
Ca and phosphate ions (Figures 3, 4). Overall, these findings
imply that the incorporation of Se and catechins into HAp
lattices did not alter the primary features of HAp nanoparticles
including the physical dimension, geometrical shape, and crystal
lattice. The integrated Se have the potential to be delivered via a
degradation-mediated sustained release.
In vitro Cytotoxicity of CC/Se-HAp
Nanomaterials
The in vitro anticancer activity of CC/Se-HAp nanomaterials
was investigated against MNNG/HOS cells, using CCK-8 assay
kit. The principle of this assay is that the color of developing
substrate WST-8 is reduced by the intracellular dehydrogenase
in live cells to water-soluble orange colored formazan, which is
directly quantified photo-metrically and its absorbance reflects
the number of viable cells in the culture medium (47). As shown
in Figure 5A, the Se-HAp is much less toxic to MNNG/HOS
cells as compared to CC/Se-HAp, confirming the improved
activity of CC/Se-HAp against MNNG/HOS cells upon catechins
modification. Further, CC/Se-HAp-3 showed high toxicity
toward the cells as compared to CC/Se-HAp-1 and CC/Se-
HAp-2 nanocomposites. In contrast, the Se-HAp nanoparticles
showed toxicity toward MNNG/HOS; however, it was much
lower than CC/Se-HAp nanocomposites. To investigate the
safety of the developed CC/Se-HAp nanocomposites toward the
normal cells, their toxicity effect was determined toward the stem
cells (hBMSCs) and the results are shown in Figure 5B. The
results showed significantly higher toxicity of Se-HAp toward
hBMSCs as compared to CC/Se-HAp. Furthermore, the response
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FIGURE 4 | Field-emission scanning electron micrographs and XRF spectra (inset) of (A) pristine HAp nanoparticles, and (B) Se-HAp, (C) CC/Se-HAp1, (D)
CC/Se-HAp2, and (E) CC/Se-HAp3 nanocomposites.
of CC/Se-HAp to MNNG/HOS and its degradation behavior
was also confirmed by cytotoxicity evaluation. It indicated that
incubation time was directly associated with the cytotoxicity
of nanoparticles (Figure 5C). For instance, the cell viability
was mainly associated with the degradation of nanoparticles.
Cell viabilities of CC/Se-HAp-3, CC/Se-HAp-2, CC/Se-HAp-
1, Se-HAp, Se, and HAp were 98, 91, 98, 81, 76, and 100%,
respectively, after the interaction of cells and nanoparticle for
6 h. Moreover, these viability values were 5, 14, 28, 37, 29,
and 100%, respectively, after cell-nanoparticles interaction for
48 h. Se (representation for Na2SeO3) was used as a positive
inhibition control, which showed prominent inhibition effect.
Surprisingly, the inhibition effect of Se-HAp was superior to
CC/Se-HAp up to 18 h; however, the cytotoxicity of CC/Se-
HAp nanoparticles increased continuously until the maximum
incubation period of 48 h. These results indicate that catechins
and selenium contents of CC/Se-HAp affect the cell viability
and lysosomal permeability. Higher catechin contents along
with selenium in CC/Se-HAp nanomaterials result in lower cell
viability due to faster degradation rate. The apoptosis during
earlier incubation (0–24 h) might be attributed to the phase of
burst release, whereas the high cytotoxic effect could be due to
the sustained release during the extended incubation (24–48 h).
These results demonstrate that catechins modification of Se-HAp
increased its toxicity toward the cancer cell lines (MNNG/HOS)
due to their degradation within the cell.
Internalization and ROS Generation
TEM micrographs indicated the internalization of CC/Se-
HAp nanomaterials into MNNG/HOS cells via endocytosis.
After encapsulated in the endosomes, the nanomaterials were
transported to lysosome for intracellular degradation (Figure 6C,
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FIGURE 5 | (A) Cytotoxicity analysis of human osteosarcoma cell line (MNNG/HOS) against Se-HAp and its modification with different concentrations of catechins,
i.e., 5% (CC/Se-HAp1), 7% (CC/Se-HAp2), and 10% (CC/Se-HAp3) relative to control. (B) Viability analysis of human bone marrow stem cells (hBMSCs) on Se-HAp
and its modification with 5% catechins (i.e., CC/Se-HAp1) and 10% catechins (i.e., CC/Se-HAp3) relative to control. (C) ROS inhibitor attenuated the cytotoxic effect of
nanoparticles, which resulted in higher cell viability. *p < 0.01, **p < 0.001, ***p < 0.0001 indicate significant differences of CC/Se-HAp-3 in comparison with Se-HAp.
Figure S3) and increasing lysosomal permeability. The gradual
degradation of internalized nanomaterials in the lysosomes
was confirmed by their gradually increased activity with the
incubation time. The anticancer drugs have been extensively
reported to kill the cancer cells through ROS generation (16,
25, 48). Therefore, we investigated the underlying mechanism
of CC/Se-HAp mediated apoptosis of cancer cells through ROS
generation by hypothesizing that CC/Se-HAp nanomaterials
can induce ROS production in mitochondria. To verify the
proposed hypothesis, we detected the ROS generation at specific
time intervals (0, 6, 8, 12, 18, and 24 h) by monitoring the
“fluorescent product of DCF.” This unique ROS indicator was
generated during the processes of ROS production (Figure 6A).
The results showed the highest level of DCF in response to
the treatment of cancer cells with CC/Se-HAp-3. This analysis
further indicated that CC/Se-HAp-3 nanoparticles induced
highest ROS production after cell-nanomaterials interaction for
18 h. This ROS produced level was significantly higher than
that of Se-HAp and Se (Na2SeO3). These results depicted that
such a low cell viability caused by CC/Se-HAp was induced
by ROS generation that caused cell apoptosis. To further
confirm these results, we inhibited the ROS generation by
treating the cancer cells with N-acetylcysteine (NAC) prior to
nanoparticles treatment. With this treatment, the CC/Se-HAp-
3 treatment indicated almost 100% cell viability of cancer cells,
as the nanoparticles could not induce the apoptosis after the
inhibition of intracellular ROS generation (Figure 6B). The
inhibition of ROS generation also inhibited the cytotoxic effect
of nanoparticles (Figure 6C). Therefore, these results depicted
that ROS generation is a key player in the process of CC/Se-HAp
mediated cancer cells apoptosis.
Regulation of Apoptosis-Associated Genes
The expression ratios of CASP-3, CASP-9, TP-53, COX-2, BCL-
2, BAX, NF-kB, and FAK (PTK-2) in MNNG/HOS cells treated
with nanomaterials for 24 h in comparison with non-treated cells,
using qPCR are shown in Figure 7A. These findings demonstrate
that the relative expressions of P-53, CASP-3, and BAX genes
were significantly upregulated, while that of BCL-2 and COX-
2 were slightly reduced. To further confirm the qPCR results of
the ROS and apoptosis-related genes, their expression levels were
measured using western blot technique. According to the western
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FIGURE 6 | ROS generation and internalization of nanoparticles. (A) Relative fluorescence intensity of DCF (percent) generated during the process of ROS formation
demonstrated that CC/Se-HAp exhibited a remarkable increase in DCF, as compared to Se-HAp or Na2SeO3. (B) Relative fluorescence intensity of DCF (percent) in
presence of ROS inhibitor was non-detectable in presence of both catechin and selenium. (C) TEM micrographs illustrating the internalization of CC/Se-HAp
nanomaterials into the human osteosarcoma cell through a typical endocytosis process. TEM images show that the nanoparticles were internalized by human
osteosarcoma cells through a typical endocytosis process. Yellow dotted lines describe cell membrane invagination that is followed by endosome formation. Red
arrows specifying region indicates newly generated endosomes loaded with nanoparticles. Green arrows determine the primary lysosome combined with the
endosome. White arrows denote the degradation and release of active agents. Blue arrows represent the noticeable degradation of nanoparticles within the lysosome
(secondary). Yellow arrows represent the nanoparticles in the vicinity of the nucleus (probably lysosomal disruption). *p < 0.01 indicates significant differences of ROS
generation in response to CC/Se-HAp treatment in comparison with Se-HAp treatment.
blot results, bcl-2, cox-2, and fak were down-regulated whereas
caspase-3, caspase-9, p-53, nf-kb, and bax were upregulated
in osteosarcoma cells in response to CC/Se-HAp nanoparticles
treatment as compared to control (Figure 7C). These results are
consistent with the qPCR results, which in turn are consistent
with ROS generation and apoptosis.
It is well-documented that ROS generation induces caspase
activation (17). Therefore, activation of caspase-3 was confirmed
using CaspACE Assay System. The results showed that
CC/Se-HAp induced caspase-3 activation in osteosarcoma cells
(Figure 7B). The quantitative analysis showed that CC/Se-
HAp activated higher levels of caspase-3 as compared to Se-
HAp. These results strengthen the ROS-mediated apoptosis in
CC/Se-HAP treated cancer cells. To further confirm the caspase-
3 activation, the CC/Se-HAp-induced caspase-3 activity was
determined by treating the osteosarcoma cells with caspase
inhibitor using NAC. This treatment indicated similar caspase-
3 levels in cancer cells treated with CC/Se-HAp-3, Se-HAp,
and control. To further analyze the apoptotic effect of CC/Se-
HAp nanoparticles, the osteosarcoma cells were treated with
nanomaterials and analyzed through flow DAPI staining.
The results demonstrated that nuclei of cells treated with
nanomaterials were smaller and brighter stained with the
crescent shape as compared to that of control cells which
possessed intact and rounded nuclei with diffuse DAPI staining
(Figure 7D). Furthermore, the cells showed separate globular
structures (apoptotic bodies) around the periphery. The DAPI
staining showed a dramatic increase in the number of apoptotic
cells treated with CC/Se-HAp nanoparticles. DAPI staining
revealed that exposure of cells to nanoparticles markedly
increased the apoptosis, coincidently with the cytotoxicity test.
In contrast, annexin V-FITC staining showed the notable
percentage of early and late apoptotic cells in response to
CC/Se-HAp treatment as compared to cells treated with
Na2SeO3 (Figures S2, S3). These results demonstrate that
CC/-Se-HAp nanomaterials enhanced the cellular apoptosis.
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FIGURE 7 | Molecular analysis associated with apoptosis of MNNG/HOS cells treated with nanoparticles. (A) Expression levels of genes (analyzed through qPCR)
associated with cancer and/or apoptosis were altered, which indicate their association with nanoparticles treatment. (B) The caspase-3 activity assay was evaluated
by using the CaspACE Assay System. The increase in caspase-3 determines that CC/Se-HAp-mediated apoptosis is involved caspase-3 pathway. (C) Key proteins
involved in apoptosis and cancer were analyzed using western blot in order to confirm the qPCR results. Western blot indicates the alteration in protein levels in
response to treatment of nanoparticles. (D) The qualitative analysis of apoptosis using fluorescence cytometry confirms the effectiveness of nanoparticles. *p < 0.05
and **p < 0.01 indicate significant differences in comparison with control.
Overall, these results indicate that two agents (i.e., catechins
and selenium) simultaneously induced ROS generation for
subsequent activation of caspase-3 and upregulation of P53,
which led to higher apoptosis of cancer cells.
DISCUSSION
Natural bone is a hierarchically structured material assembled
from basic building blocks of mineral nanoparticles in the frame
of bone tissues and collagen protein, which become weak as
a result of osteosarcoma (49). To treat osteosarcoma, different
strategies including tissues cleaning and bone surgery are
currently in practice; however, such strategies are not as accurate
and lead to physical disability and recurrence of osteosarcoma.
Therefore, targeted and specific therapeutic agents are required
to completely kill the cancer cells. Hydroxyapatite is the main
inorganic mineral in vertebrate bones and tooth enamels that
has been extensively studied as excellent bone substitutes. Its
doping with selenium has been reported previously as a potential
anticancer agent (16, 17); however, it is toxic toward the
normal cells when used at higher concentrations. Therefore,
modification of Se-HAp nanoparticles with other anticancer
agents, such as catechins, could be used to protect bone cancer
metastasis and potentiate cancer cells removal. In the current
study, a series of catechins-modified Se-doped HAp (CC/Se-
HAp) nanocomposites were prepared and characterized for
various physico-chemical and biological properties. In addition,
the nanomaterials were evaluated for their size, morphology, and
colloidal stability which are important factors in the designing of
nanoparticles (39). Further, the developed nanomaterials showed
a higher anticancer activity as compared to Se-HAp nanoparticles
in vitro.
As reported previously, the nanoparticles having a size
<100 nm possess better cell endocytosis (50–53) and mechanical
compatibility with natural bone can effectively promote
osteogenesis (54, 55). To this end, the developed nanoscale
HAp nanoparticles (60 ± 15) can serve as ideal template for the
development of new bone and effective nanocarrier in anticancer
drug delivery system. TEM micrographs (Figure 3), showed
that the developed nanomaterials possessed nano-dimensional
size and single crystalline structure. Moreover, the CC/Se-
HAp nanomaterials existed in a uniaxial-like form, i.e., larger
dimensions in length (axial) and smaller dimensions in width
(equatorial). Further, FTIR spectrum of pristine HAp showed
the distinctive peaks for the triply degenerate υ3 asymmetric and
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non-degenerate υ1 symmetric of P-O stretching vibrations were
present between 1,200 and 900 cm−1, which are in agreement
with a previous report (46). Similarly, the double degenerate υ2
and triple degenerate υ4 bending of O-P-O were present between
600 and 400 cm−1 for all samples which is in accordance with
the typical FTIR pattern of HAp (15, 41, 56).
Both selenium and catechin doses separately have been
reported to have direct cytotoxic effects on malignant tumors in
vitro and in vivo (16, 29, 31, 48). However, these particles are
far behind the clinical studies due to their toxicity toward the
normal cells and show low activity against cancer cells. Therefore,
combining catechins with Se-HAp is expected to minimize the
toxic effects of selenium toward the normal cells. Our data
showed that CC/Se-HAp nanoparticles caused tumor growth
inhibition through ROS generation in P53 mediated pathway,
as indicated by the higher ROS generation and increased P53
levels (Figures 7A,D). Previous in vitro studies showed that
Se-HAp nanoparticles induce ROS generation that leads to
apoptosis (16). Comparatively, our data showed that CC/Se-
HAp can induce higher cancer cell apoptosis (Figure 7A). In
addition, the cytotoxicity results of CC/Se-HAp nanomaterials
are comparable with a study which showed that nanoparticles
with a size <100 nm possess better cell endocytosis efficiency
as compared to those with a larger size (16). Therefore, the
needle-like HAp nanoparticles prepared in the present study
were expected to induce cytotoxicity and can effectively promote
osteogenesis, as reported previously (16).
Generally, the cell viability is associated with the degradation
of nanoparticles; therefore, the cell apoptosis was sufficiently
higher after the cell-nanoparticles interactions for 24 h. These
findings imply that Se and catechin contents in CC/Se-HAp
nanoparticles after degradation in lysosome led to cell apoptosis.
Researchers have explored the antitumor potential of different
nanoparticles through ROS induction. For instance, Zn2+
could trigger ROS generation, thereby activates a p53-mediated
apoptotic pathway (16, 57). Furthermore, catechins selectively
induce ROS generation only in cancer cells (25). In current study,
the higher levels of P53 and caspase-3 indicate the antitumor
activities of selenium ions and catechin contents due to ROS
generation. These findings are consistent with the earlier studies
which showed that ROS generation could induce cancer cells
apoptosis in P53 dependent pathway with the involvement of
caspase-3 (16, 25). Studies have also shown that P53 activation
in cancer cells induces the expression of P53 target genes which
further leads to cell growth inhibition and apoptosis. Catechins
also induce the activation of P53 in cancer cells (25, 58).
Therefore, it is anticipated that CC/Se-HAp could affect the P53
mediated apoptosis pathway in a similar fashion. Furthermore,
the internalization of nanoparticles on the surface is associated
with the actin rearrangement near the plasma membrane
and extension into the extracellular space (38). Similarly,
the TEM micrographs (Figure 6C) revealed that most of the
nanoparticles were rapidly internalized into the MNNG/HOS
cells. This observation confirms the internalization and
translocation of CC/Se-HAp nanoparticles. These observations
are also in agreement with a previous report (16). Finally,
the degradation of internalized CC/Se-HAp nanomaterials
restrains the viability of cells as indicated by the reduced cell
viability (Figure 6A). Furthermore, the internalization indicates
that the nanomaterials were gradually degraded within the
lysosomes with the increased incubation time, which is in
agreement with a previously reported study of Se-doped HAp
nanoparticles (16).
Overall, the results of present study indicate that CC/Se-HAp
nanoparticles have the greater potency for the targeted treatment
of the osteosarcoma with least side effects toward the normal
stem cells. However, further analysis like release mechanism,
release kinetics, action mechanism, and fate of the released
particles from nanomaterials at different pH and with different
concentrations of catechins and selenium, would provide the
base for clinical trials of the developed therapeutic drug in the
osteosarcoma therapy.
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